Article info

Download PDFPDF
Extended report
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial

Authors

  1. Correspondence to Dr Johan Anders Karlsson, Reumatologiska kliniken, Skånes universitetssjukhus, Lund, Kioskgatan 3, Lund 22185, Sweden; Johan.81.karlsson{at}gmail.com
View Full Text

Citation

Karlsson JA, Neovius M, Nilsson J, et al
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial

Publication history

  • Received May 21, 2012
  • Accepted October 28, 2012
  • First published November 29, 2012.
Online issue publication 
November 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.